Evidence map›Paper›PMID 30197756›Full record

ArticleOncotarget2018

SPIN1 is a proto-oncogene and SPIN3 is a tumor suppressor in human seminoma.

Damian Mikolaj Janecki, Marcin Sajek, Maciej Jerzy Smialek, Maciej Kotecki, Barbara Ginter-Matuszewska, Bogna Kuczynska, Anna Spik, Tomasz Kolanowski, Riko Kitazawa, Maciej Kurpisz and 1 more

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Immune-modulatory effects of Spindlin-1 inhibitors.Clinical and experimental immunology · 2025
    Article
  4. An integrated structural model of the DNA damage-responsive H3K4me3 binding WDR76:SPIN1 complex with the nucleosome.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  5. Review
  6. Article
  7. Identification ofOncology letters · 2021
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Cellular consequences of arginine methylation.Cellular and molecular life sciences : CMLS · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 3 countries.

Damian Mikolaj JaneckiInstitute of Human Genetics, Polish Academy of Sciences, Poznan, Poland.
Marcin SajekInstitute of Human Genetics, Polish Academy of Sciences, Poznan, Poland.
Maciej Jerzy SmialekInstitute of Human Genetics, Polish Academy of Sciences, Poznan, Poland.
Maciej KoteckiInstitute of Human Genetics, Polish Academy of Sciences, Poznan, Poland.
Barbara Ginter-MatuszewskaInstitute of Human Genetics, Polish Academy of Sciences, Poznan, Poland.
Bogna KuczynskaInstitute of Human Genetics, Polish Academy of Sciences, Poznan, Poland.
Anna SpikInstitute of Human Genetics, Polish Academy of Sciences, Poznan, Poland.
Tomasz KolanowskiInstitute of Human Genetics, Polish Academy of Sciences, Poznan, Poland.
Riko KitazawaDivision of Molecular Pathology, Ehime University, Graduate School of Medicine, Shitsukawa, Toon City, Ehime, Japan.
Maciej KurpiszInstitute of Human Genetics, Polish Academy of Sciences, Poznan, Poland.
Jadwiga JaruzelskaInstitute of Human Genetics, Polish Academy of Sciences, Poznan, Poland.
Institute of Human Genetics · PLPolish Academy of Sciences · PLEhime University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

SPIN1 is necessary for normal meiotic progression in mammals. It is overexpressed in human ovarian cancers and some cancer cell lines. Here, we examined the functional significance and regulation of SPIN1 and SPIN3 in the TCam-2 human seminoma cell line. We found that while SPIN1 overexpression reduced apoptosis in these cells, SPIN3 overexpression induced it. Similarly, SPIN1 upregulated and SPIN3 downregulated CYCD1, which is a downstream target of the PI3K/AKT pathway and contributes to apoptosis resistance in cancer cell lines. It appears that SPIN1 is pro-oncogenic and SPIN3 acts as a tumor suppressor in TCam-2 cells. To our knowledge, this is the first report of SPIN3 tumor suppressor activity. However, both SPIN1 and SPIN3 stimulated cell cycle progression. In addition, using luciferase reporters carrying

Indexed as

human seminomaPUM proteinsSPIN1SPIN3testis germ cell tumors

Identifiers

PMID30197756
PMCPMC6126697
OpenAlexW2888185505

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.